Drug evaluation after marketing
After marketing, drugs should be evaluated for safety and for efficacy. Present national systems are inadequate for both tasks. Safety can be evaluated by means of nonexperimental research, whereas evaluation of efficacy in a variety of settings representing normal medical practice generally require...
Saved in:
Published in | Annals of internal medicine Vol. 90; no. 2; p. 257 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.02.1979
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!